Day: February 28, 2025

Beijing, Feb. 28, 2025 (GLOBE NEWSWIRE) — AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, announced today a strategic partnership agreement (the “Agreement”) with HashBeaver, a cloud mining platform in the digital currency financial sector. This collaboration aims to join AGM Holdings’ mining resources in Canada alongside HashBeaver’s expertise in computing power services to advance innovations in Bitcoin mining and artificial intelligence (“AI”) services. The partnership marks a pivotal step in AGM Holdings’ strategy for sustainable growth and technological leadership. By integrating AGM Holdings’ robust infrastructure with HashBeaver’s innovative cloud mining solutions, the...

DURHAM, N.C., Feb. 28, 2025 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 11, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company’s website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 10, 2026. About BioventusBioventus...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) — In a recent edition of the Emerging Markets Report we brought to your attention a compelling story in the phosphate industry. We outlined the correlation between phosphate and the Electric Vehicle (EV) industry and how if one believed in the future of EVs, that phosphate deals were a natural extension to explore. You can read that essay on First Phosphate Corp. (CSE: PHOS) (OTCQB: FRSPF) (FSE: KD0) at this link. Just a few days ago, First Phosphate dropped a nuts and bolts press release about their progress. There are no glaring headlines, no bold claims, no saucy hyperbole in flourished CEO quotes. Instead, there is a significant update not often seen in public company parlance that gives you a real understanding of where the Company is in...

28. February 2025 News Release: The board has decided that Pharma Equity Group A/S will in future only submit half-yearly financial reports. This means changes to the previously announced financial calendar for 2025. The current financial calendar for 2025 will look like this:  Pharma Equity Group2025 Financial Calendar  ​March 4 Deadline for shareholder proposals – Annual General meeting​  ​March 20 ​Annual Report 2024​  April 16 Annual General Meeting​  August 14 Interim Report – for the six-month period ended June 30, 2025​  ​Contact person – Investor Relations On the Company’s website www.pharmaequitygroup.com further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114...

TARRYTOWN, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of linvoseltamab to treat adults with relapsed and refractory (R/R) multiple myeloma (MM). The recommendation is specific to those who have received at least three prior therapies, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy. The European Commission is expected to announce a final decision in the coming months. The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults...

LATHAM, N.Y., Feb. 28, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of hydrogen solutions, today announced the adoption of an executive compensation program that enables eligible executives to receive up to 75% of their compensation in the form of Plug stock. This initiative underscores the company’s commitment to aligning leadership interests with long-term shareholder value. “As Plug continues to execute on its strategy, this program reinforces our leadership’s confidence in the company’s future and commitment to driving sustainable growth,” said Andy Marsh, CEO of Plug. “Any of us that choose to opt into this program will have an increased equity stake, and be further aligned with the investors and stakeholders who believe in our long-term vision.” Under the program, eligible executives may elect...